Table 3 Comparison of radiographic and laboratory results between control and interventional arm
Control arm (untreated cases) | Intervention arm (treated cases) | Test of significance | |
|---|---|---|---|
Fibroscan | |||
1 | 27.0 (15.0–73.0) | 21.6 (8.9–75.0) | P=0.167 |
2 | 21.3 (12.5–175.0) | 16.8 (2.9–68.3) | P=0.07 |
3 | 17.40 (10.3–27.0) | 14.3 (2.9–56.0) | P=0.111 |
Test of significance between pre and post treatment | P1=0.05 P2=0.005* P3=0.001* | P1=0.001* P2=0.001* P3=0.001* | |
FIB-4 | |||
1 | 2.76 (0.93–9.030 | 2.38 (0.82–20.68) | P=0.511 |
2 | 2.01 (0.58–8.74) | 2.289 (0.58–16.39) | P=0.949 |
3 | 2.10 (0.74–6.89) | 2.065 (0.58–17.64) | P=0.956 |
Test of significance between pre and post treatment | P1=0.156 P2=0.019* P3=0.221 | P1=0.003* P2=0.002* P3=0.383 | |
ALT | |||
1 | 32.0 (15.0–88.0) | 27.0 (2.0–78.0) | P=0.08 |
2 | 28.0 (15.0–59.0) | 26.0 (10.0–128.0) | P=0.272 |
3 | 28.0 (18.0–43.00 | 24.0 (8.0–86.0) | P=0.059 |
Test of significance between pre and post treatment | P1=0.271 P2=0.362 P3=0.969 | P1=0.507 P2=0.009* P3=0.026* | |
AST | |||
1 | 38 (17–94) | 34 (11–85) | P=0.233 |
2 | 32 (17–79) | 28 (11–92) | P=0.143 |
3 | 28.5 (20–45) | 27 (7–96) | P=0.690 |
Test of significance between pre and post treatment | P1=0.300 P2=0.064 P3=0.02* | P1=0.019* P2<0.001* P3=0.003* | |
Platelets | |||
1 | 147 (57–259) | 145 (33–343) | P=0.954 |
2 | 154 (61–355) | 148 (30–374) | P=0.347 |
3 | 146 (65–280) | 145 (37–333) | P=0.639 |
Test of significance between pre and post treatment | P1=0.101 P2=0.414 P3=0.014* | P1=0.275 P2=0.844 P3=0.021* | |
Bilirubin | |||
1 | 0.90 (0.3–2.0) | 0.90 (0.30–2.50 | P=0.734 |
2 | 0.80 (0.5–1.4) | 0.90 (0.3–5.0) | P=0.539 |
3 | 0.85 (0.7–2.5) | 0.90 (0.3–5.0) | P=0.701 |
Test of significance between pre and post treatment | P1=0.798 P2=0.306 P3=0.107 | P1=0.726 P2=0.169 P3=0.061 | |
Albumin | |||
1 | 3.93±0.53 | 4.16±0.39 | P=0.04* |
2 | 4.19±0.48 | 4.08±0.49 | P=0.408 |
3 | 4.09±0.33 | 4.05±0.39 | P=0.718 |
Test of significance between pre and post treatment | P1=0.133 P2=0.606 P3=0.123 | P1=0.096 P2=0.007* P3=0.365 | |
EGD1 | |||
OVs | 0 | 50 (4.0) | P=0.645 |
PHG | 0 | 30 (2.4) | |
Both | 10 (6.7) | 60 (4.8) | |
Free | 0 | 30 (2.4) | |
EGD2 | |||
OVs | 0 | 10 (0.8) | P=0.133 |
PHG | 10 (6.7) | 60 (4.8) | |
Both | 10 (6.7) | 0 (0.0) | |
Free | 0 | 0 (0.0) | |
EGD3 | |||
PHG | 20 (13.3) | 40 (3.2) | P=0.125 |
Test of significance between pre and post treatment | P1=0.317 P2=1.0 P3=0.317 | P1=0.180 P2=1.0 P3=1.0 | |